ACM
Aisling Capital Management Portfolio holdings
AUM
$360M
This Quarter Return
-5.49%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$625M
AUM Growth
+$625M
(+12%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
16.96%
Top 10 Holdings %
Top 10 Hldgs %
88.98%
Holding
21
New
6
Increased
–
Reduced
–
Closed
–
Top Buys
1 |
ELEV
Elevation Oncology
ELEV
|
$38.5M |
2 |
Monte Rosa Therapeutics
GLUE
|
$33.4M |
3 |
Biomea Fusion
BMEA
|
$12.5M |
4 |
Tourmaline Bio
TRML
|
$10M |
5 |
OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
|
$8.27M |
Top Sells
No sells this quarter
Sector Composition
1 | Healthcare | 100% |